首页 | 本学科首页   官方微博 | 高级检索  
     


Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic‐phase chronic myeloid leukemia
Authors:Shuichi Ota  Toshihiro Matsukawa  Satoshi Yamamoto  Shinichi Ito  Motohiro Shindo  Kazuya Sato  Takeshi Kondo  Kyuhei Kohda  Hajime Sakai  Akio Mori  Tohru Takahashi  Hiroshi Ikeda  Hiroyuki Kuroda  Yoshihito Haseyama  Masaki Yamamoto  Takeo Sarashina  Makoto Yoshida  Ryoji Kobayashi  Mitsufumi Nishio  Toshimichi Ishihara  Yasuo Hirayama  Yasutaka Kakinoki  Hajime Kobayashi  Takashi Fukuhara  Masahiro Imamura  Mitsutoshi Kurosawa
Affiliation:1. Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan;2. Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan;3. Department of Hematology, Sapporo City General Hospital, Sapporo, Japan;4. Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan;5. Department of Hematology, Asahikawa Medical University, Asahikawa, Japan;6. Department of Hematology/Oncology, Asahikawa Kosei Hospital, Asahikawa, Japan;7. Faculty of Medicine and Graduate School of Medicine, Department of Hematology, Hokkaido University, Sapporo, Japan;8. Department of Hematology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan;9. Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan;10. Department of Hematology, Aiiku Hospital, Sapporo, Japan;11. Department of Hematology, Tenshi Hospital, Sapporo, Japan;12. Department of Hematology, Sapporo Medical University, Sapporo, Japan;13. Department of Hematology, Steel Memorial Muroran Hospital, Muroran, Japan;14. Department of Hematology, Tonan Hospital, Sapporo, Japan;15. Department of Pediatrics, Sapporo Medical University, Sapporo, Japan;16. Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan;17. Department of Pediatrics, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan;18. Department of Hematology/Oncology for Children and Adolescent, Sapporo Hokuyu Hospital, Sapporo, Japan;19. Department of Hematology and Oncology, NTT East Japan Sapporo Hospital, Sapporo, Japan;20. Department of Hematology, Kin‐ikyo Chuo Hospital, Sapporo, Japan;21. Department of Hematology, Higashisapporo Hospital, Sapporo, Japan;22. Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan;23. Department of Hematology, Obihiro Kosei Hospital, Obihiro, Japan;24. Palliative Care Center, Sapporo Kosei Hospital, Sapporo, Japan;25. Department of Hematology, Hokkaido Cancer Center, Sapporo, Japan
Abstract:
Keywords:adverse events  chronic myeloid leukemia  dasatinib  imatinib  nilotinib  tyrosine kinase inhibitor
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号